nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—Bad taste—Hydrochlorothiazide—nephrolithiasis	0.0535	0.0741	CcSEcCtD
Trazodone—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0276	0.0382	CcSEcCtD
Trazodone—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0241	0.0334	CcSEcCtD
Trazodone—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0238	CcSEcCtD
Trazodone—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0226	CcSEcCtD
Trazodone—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0216	CcSEcCtD
Trazodone—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0213	CcSEcCtD
Trazodone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0209	CcSEcCtD
Trazodone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.015	0.0207	CcSEcCtD
Trazodone—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0192	CcSEcCtD
Trazodone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0191	CcSEcCtD
Trazodone—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0187	CcSEcCtD
Trazodone—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0155	CcSEcCtD
Trazodone—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0155	CcSEcCtD
Trazodone—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0111	0.0531	CbGpPWpGaD
Trazodone—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0151	CcSEcCtD
Trazodone—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0149	CcSEcCtD
Trazodone—Ziprasidone—CHRM3—nephrolithiasis	0.0107	0.313	CrCbGaD
Trazodone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0147	CcSEcCtD
Trazodone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0145	CcSEcCtD
Trazodone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0143	CcSEcCtD
Trazodone—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0143	CcSEcCtD
Trazodone—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00986	0.0136	CcSEcCtD
Trazodone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00974	0.0135	CcSEcCtD
Trazodone—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0134	CcSEcCtD
Trazodone—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00923	0.0128	CcSEcCtD
Trazodone—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00897	0.0124	CcSEcCtD
Trazodone—Aripiprazole—CHRM3—nephrolithiasis	0.00835	0.245	CrCbGaD
Trazodone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00784	0.0108	CcSEcCtD
Trazodone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00781	0.0108	CcSEcCtD
Trazodone—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0107	CcSEcCtD
Trazodone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00772	0.0107	CcSEcCtD
Trazodone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00746	0.0103	CcSEcCtD
Trazodone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00742	0.0103	CcSEcCtD
Trazodone—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00737	0.0102	CcSEcCtD
Trazodone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00725	0.01	CcSEcCtD
Trazodone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00721	0.00998	CcSEcCtD
Trazodone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00691	0.00957	CcSEcCtD
Trazodone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00935	CcSEcCtD
Trazodone—HTR2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00672	0.0321	CbGpPWpGaD
Trazodone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00906	CcSEcCtD
Trazodone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00876	CcSEcCtD
Trazodone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0063	0.00872	CcSEcCtD
Trazodone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00607	0.0084	CcSEcCtD
Trazodone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.006	0.00831	CcSEcCtD
Trazodone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00806	CcSEcCtD
Trazodone—Tension—Hydrochlorothiazide—nephrolithiasis	0.0058	0.00803	CcSEcCtD
Trazodone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00801	CcSEcCtD
Trazodone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00795	CcSEcCtD
Trazodone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00792	CcSEcCtD
Trazodone—HTR2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00565	0.027	CbGpPWpGaD
Trazodone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00557	0.00771	CcSEcCtD
Trazodone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00767	CcSEcCtD
Trazodone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00759	CcSEcCtD
Trazodone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00756	CcSEcCtD
Trazodone—HTR1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00545	0.0261	CbGpPWpGaD
Trazodone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00752	CcSEcCtD
Trazodone—HTR2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00542	0.0259	CbGpPWpGaD
Trazodone—Loxapine—CHRM3—nephrolithiasis	0.00535	0.157	CrCbGaD
Trazodone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00738	CcSEcCtD
Trazodone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00735	CcSEcCtD
Trazodone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0053	0.00734	CcSEcCtD
Trazodone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00723	CcSEcCtD
Trazodone—Quetiapine—CHRM3—nephrolithiasis	0.00522	0.153	CrCbGaD
Trazodone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0052	0.00719	CcSEcCtD
Trazodone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00697	CcSEcCtD
Trazodone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00697	CcSEcCtD
Trazodone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00697	CcSEcCtD
Trazodone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00502	0.00694	CcSEcCtD
Trazodone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00688	CcSEcCtD
Trazodone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00681	CcSEcCtD
Trazodone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00673	CcSEcCtD
Trazodone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00668	CcSEcCtD
Trazodone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00657	CcSEcCtD
Trazodone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00652	CcSEcCtD
Trazodone—HTR2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00471	0.0225	CbGpPWpGaD
Trazodone—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0047	0.0225	CbGpPWpGaD
Trazodone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00646	CcSEcCtD
Trazodone—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00461	0.022	CbGpPWpGaD
Trazodone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00637	CcSEcCtD
Trazodone—HTR1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00458	0.0219	CbGpPWpGaD
Trazodone—HTR2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00455	0.0218	CbGpPWpGaD
Trazodone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00624	CcSEcCtD
Trazodone—Clozapine—CHRM3—nephrolithiasis	0.00449	0.132	CrCbGaD
Trazodone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00608	CcSEcCtD
Trazodone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00604	CcSEcCtD
Trazodone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00433	0.006	CcSEcCtD
Trazodone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00595	CcSEcCtD
Trazodone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00594	CcSEcCtD
Trazodone—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00428	0.0205	CbGpPWpGaD
Trazodone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00581	CcSEcCtD
Trazodone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00576	CcSEcCtD
Trazodone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00571	CcSEcCtD
Trazodone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00571	CcSEcCtD
Trazodone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00398	0.0055	CcSEcCtD
Trazodone—HTR2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00396	0.0189	CbGpPWpGaD
Trazodone—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00395	0.0189	CbGpPWpGaD
Trazodone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00546	CcSEcCtD
Trazodone—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00387	0.0185	CbGpPWpGaD
Trazodone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00531	CcSEcCtD
Trazodone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00528	CcSEcCtD
Trazodone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00528	CcSEcCtD
Trazodone—HTR2A—urine—nephrolithiasis	0.00381	0.111	CbGeAlD
Trazodone—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00369	0.0177	CbGpPWpGaD
Trazodone—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0036	0.0172	CbGpPWpGaD
Trazodone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00492	CcSEcCtD
Trazodone—CYP3A4—urine—nephrolithiasis	0.00353	0.102	CbGeAlD
Trazodone—CYP2D6—urine—nephrolithiasis	0.00347	0.101	CbGeAlD
Trazodone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00479	CcSEcCtD
Trazodone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00472	CcSEcCtD
Trazodone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00457	CcSEcCtD
Trazodone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00442	CcSEcCtD
Trazodone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00425	CcSEcCtD
Trazodone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00306	0.0888	CbGeAlD
Trazodone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00421	CcSEcCtD
Trazodone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00421	CcSEcCtD
Trazodone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00418	CcSEcCtD
Trazodone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00397	CcSEcCtD
Trazodone—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00282	0.0135	CbGpPWpGaD
Trazodone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00262	0.076	CbGeAlD
Trazodone—HTR2B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00232	0.0111	CbGpPWpGaD
Trazodone—HTR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00232	0.0111	CbGpPWpGaD
Trazodone—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00225	0.0108	CbGpPWpGaD
Trazodone—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00217	0.0104	CbGpPWpGaD
Trazodone—HTR2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00209	0.01	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00207	0.00993	CbGpPWpGaD
Trazodone—HTR2C—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00187	0.00895	CbGpPWpGaD
Trazodone—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00182	0.00872	CbGpPWpGaD
Trazodone—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00171	0.00818	CbGpPWpGaD
Trazodone—HTR2B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00168	0.00802	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00167	0.00801	CbGpPWpGaD
Trazodone—HTR2B—cortex of kidney—nephrolithiasis	0.00165	0.0477	CbGeAlD
Trazodone—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.00162	0.00778	CbGpPWpGaD
Trazodone—HTR2A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00162	0.00778	CbGpPWpGaD
Trazodone—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00162	0.00776	CbGpPWpGaD
Trazodone—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00159	0.00761	CbGpPWpGaD
Trazodone—HTR1A—renal system—nephrolithiasis	0.00157	0.0454	CbGeAlD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0015	0.00718	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00145	0.00695	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00145	0.00694	CbGpPWpGaD
Trazodone—ADRA1A—renal system—nephrolithiasis	0.00144	0.0419	CbGeAlD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00142	0.00681	CbGpPWpGaD
Trazodone—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00138	0.0066	CbGpPWpGaD
Trazodone—HTR2C—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00135	0.00647	CbGpPWpGaD
Trazodone—HTR2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0013	0.0062	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00129	0.00619	CbGpPWpGaD
Trazodone—CYP3A5—nephron tubule—nephrolithiasis	0.00127	0.0367	CbGeAlD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00121	0.00579	CbGpPWpGaD
Trazodone—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00117	0.00562	CbGpPWpGaD
Trazodone—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00117	0.00561	CbGpPWpGaD
Trazodone—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00116	0.00553	CbGpPWpGaD
Trazodone—CYP3A5—renal system—nephrolithiasis	0.00115	0.0334	CbGeAlD
Trazodone—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00115	0.0055	CbGpPWpGaD
Trazodone—CYP3A5—kidney—nephrolithiasis	0.00111	0.0323	CbGeAlD
Trazodone—HTR2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00111	0.00531	CbGpPWpGaD
Trazodone—CYP3A5—cortex of kidney—nephrolithiasis	0.00108	0.0314	CbGeAlD
Trazodone—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00105	0.00503	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00105	0.00503	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00105	0.00502	CbGpPWpGaD
Trazodone—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00105	0.005	CbGpPWpGaD
Trazodone—ADRA2A—cortex of kidney—nephrolithiasis	0.00103	0.03	CbGeAlD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00103	0.00492	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000979	0.00468	CbGpPWpGaD
Trazodone—HTR2A—renal system—nephrolithiasis	0.000933	0.0271	CbGeAlD
Trazodone—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000908	0.00435	CbGpPWpGaD
Trazodone—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000906	0.00434	CbGpPWpGaD
Trazodone—HTR2A—kidney—nephrolithiasis	0.000902	0.0262	CbGeAlD
Trazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0009	0.00431	CbGpPWpGaD
Trazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000896	0.00429	CbGpPWpGaD
Trazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000889	0.00426	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—RGS14—nephrolithiasis	0.000889	0.00425	CbGpPWpGaD
Trazodone—CYP3A4—renal system—nephrolithiasis	0.000864	0.0251	CbGeAlD
Trazodone—CYP2D6—renal system—nephrolithiasis	0.00085	0.0247	CbGeAlD
Trazodone—HTR2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000846	0.00405	CbGpPWpGaD
Trazodone—CYP3A4—kidney—nephrolithiasis	0.000835	0.0242	CbGeAlD
Trazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000826	0.00395	CbGpPWpGaD
Trazodone—CYP2D6—kidney—nephrolithiasis	0.000822	0.0238	CbGeAlD
Trazodone—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000794	0.0038	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000789	0.00378	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000779	0.00373	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000779	0.00373	CbGpPWpGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000778	0.00372	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000776	0.00372	CbGpPWpGaD
Trazodone—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.000773	0.0037	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000762	0.00365	CbGpPWpGaD
Trazodone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000755	0.00362	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000721	0.00345	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000717	0.00343	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000708	0.00339	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000695	0.00332	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000686	0.00328	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000686	0.00328	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000684	0.00327	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000682	0.00326	CbGpPWpGaD
Trazodone—ABCB1—nephron tubule—nephrolithiasis	0.000673	0.0195	CbGeAlD
Trazodone—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000671	0.00321	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.000667	0.00319	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.000667	0.00319	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000661	0.00316	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000635	0.00304	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000635	0.00304	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000627	0.003	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000624	0.00299	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000624	0.00298	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000623	0.00298	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000621	0.00297	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000617	0.00295	CbGpPWpGaD
Trazodone—ABCB1—renal system—nephrolithiasis	0.000612	0.0177	CbGeAlD
Trazodone—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00061	0.00292	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.0006	0.00287	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000592	0.00284	CbGpPWpGaD
Trazodone—ABCB1—kidney—nephrolithiasis	0.000591	0.0172	CbGeAlD
Trazodone—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000591	0.00283	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00058	0.00278	CbGpPWpGaD
Trazodone—ABCB1—cortex of kidney—nephrolithiasis	0.000576	0.0167	CbGeAlD
Trazodone—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000566	0.00271	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000542	0.00259	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000541	0.00259	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000539	0.00258	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000536	0.00257	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000533	0.00255	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000531	0.00254	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.000525	0.00251	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000507	0.00243	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000501	0.0024	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000498	0.00238	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000493	0.00236	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000487	0.00233	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000484	0.00232	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000482	0.0023	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000482	0.0023	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000478	0.00229	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000463	0.00222	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000462	0.00221	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000453	0.00217	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000452	0.00216	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000448	0.00214	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000448	0.00214	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000437	0.00209	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000434	0.00208	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000433	0.00207	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.000432	0.00207	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000426	0.00204	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.000423	0.00203	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000423	0.00203	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000421	0.00202	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000421	0.00201	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.00042	0.00201	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000412	0.00197	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.0004	0.00191	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000399	0.00191	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000399	0.00191	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.000397	0.0019	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000393	0.00188	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000388	0.00185	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000386	0.00185	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000384	0.00184	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000384	0.00184	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000383	0.00183	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.000368	0.00176	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000367	0.00176	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000367	0.00175	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00036	0.00172	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000357	0.00171	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000355	0.0017	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.000355	0.0017	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000354	0.0017	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000353	0.00169	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000352	0.00168	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00035	0.00168	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000335	0.0016	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000335	0.0016	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000334	0.0016	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000328	0.00157	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000327	0.00156	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000322	0.00154	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.00032	0.00153	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000319	0.00153	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000306	0.00147	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000306	0.00146	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000305	0.00146	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000304	0.00145	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000303	0.00145	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000303	0.00145	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000303	0.00145	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.0003	0.00143	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000298	0.00142	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000288	0.00138	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000288	0.00138	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.000286	0.00137	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000286	0.00137	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000279	0.00133	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.000278	0.00133	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000278	0.00133	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000278	0.00133	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000277	0.00133	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000277	0.00132	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000277	0.00132	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000274	0.00131	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000272	0.0013	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000261	0.00125	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000256	0.00123	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000253	0.00121	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000248	0.00119	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000248	0.00119	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000248	0.00119	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000248	0.00119	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000248	0.00119	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000247	0.00118	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000243	0.00116	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000243	0.00116	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.000234	0.00112	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000232	0.00111	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000226	0.00108	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000226	0.00108	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000216	0.00103	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.00021	0.001	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APRT—nephrolithiasis	0.00021	0.001	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000208	0.000995	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000207	0.00099	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000198	0.000948	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000198	0.000946	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000198	0.000946	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000195	0.000935	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.00019	0.00091	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.000189	0.000905	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.00018	0.00086	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000179	0.000858	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000179	0.000857	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000176	0.000842	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.00017	0.000816	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000164	0.000786	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000164	0.000784	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000163	0.000782	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000161	0.00077	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000152	0.000727	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000149	0.000715	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000149	0.000715	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000141	0.000674	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000135	0.000647	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000129	0.000618	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000129	0.000618	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000127	0.000609	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	0.000118	0.000563	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	9.55e-05	0.000457	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	9.5e-05	0.000454	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AQP1—nephrolithiasis	9.21e-05	0.000441	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	8.32e-05	0.000398	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	8.25e-05	0.000395	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SPP1—nephrolithiasis	8.23e-05	0.000394	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	8.07e-05	0.000386	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	7.5e-05	0.000359	CbGpPWpGaD
